Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresCristiana Bianco, Luca Valenti, V. Borroni et al.|Journal of Hepatology|2020Cited by 361
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in womenAlessandro Cherubini, Luca Valenti, Mahnoosh Ostadreza et al.|Nature Medicine|2023Cited by 130
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver DiseaseSerena Pelusi, Luca Valenti, Guido Baselli et al.|Scientific Reports|2019Cited by 123
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarkerGuido Baselli, Luca Valenti|Gut|2020Cited by 108
Rare ATG7 genetic variants predispose patients to severe fatty liver diseaseGuido Baselli, Marcello Dallio, Oveis Jamialahmadi et al.|Journal of Hepatology|2022Cited by 93